Literature DB >> 1388337

Ondansetron in the treatment of postoperative vomiting: a randomized, double-blind comparison with droperidol and metoclopramide.

E Alon1, S Himmelseher.   

Abstract

The prophylactic antiemetic efficacy of ondansetron was evaluated in a randomized, double-blind comparison with droperidol and metoclopramide in 66 patients undergoing general anesthesia for dilatation and curettage. Ten minutes before induction of anesthesia, 22 patients received a single intravenous dose of 8 mg of ondansetron, 22 others received 1.25 mg of droperidol, and the remaining 22 received 10 mg of metoclopramide. Anesthesia was induced with 3.3-5 mg/kg of intravenous thiopental and maintained with 65% nitrous oxide in oxygen and 2%-3% enflurane. Postoperatively, the incidence of vomiting was 13% with ondansetron, 45% with droperidol, and 54% with metoclopramide (P less than 0.05; overall chi 2 test). There was no statistically significant difference in the incidence of nausea among the groups. Postoperative sedation and well-being scores were not significantly different among the groups. We conclude that preoperative prophylactic administration of ondansetron is superior to droperidol or metoclopramide in the prevention of emetic sequelae after general anesthesia for dilatation and curettage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1388337     DOI: 10.1213/00000539-199210000-00017

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  13 in total

Review 1.  When placebo controlled trials are essential and equivalence trials are inadequate.

Authors:  M R Tramèr; D J Reynolds; R A Moore; H J McQuay
Journal:  BMJ       Date:  1998-09-26

2.  A comparison of ondansetron and prochlorperazine for the prevention of nausea and vomiting after tympanoplasty.

Authors:  A A van den Berg
Journal:  Can J Anaesth       Date:  1996-09       Impact factor: 5.063

Review 3.  Prevention and treatment of postoperative nausea and vomiting.

Authors:  A L Kovac
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

4.  Cardiovascular stability with rapid intravenous infusion of ondansetron.

Authors:  J S Heyman; M L Young; R J Bagshaw; W J Levy; R T Geer; S J Aukburg; A F Joslyn; T J Conahan
Journal:  Can J Anaesth       Date:  1993-05       Impact factor: 5.063

Review 5.  [Prophylaxis of nausea and vomiting in the postoperative phase: relative effectiveness of droperidol and metoclopramide].

Authors:  M Merker; P Kranke; A M Morin; D Rüsch; L H J Eberhart
Journal:  Anaesthesist       Date:  2010-12-12       Impact factor: 1.041

6.  Ondansetron is a better prophylactic antiemetic than droperidol for tonsillectomy in children.

Authors:  W M Splinter; E J Rhine; D W Roberts; M R Baxter; H M Gould; L E Hall; H B MacNeill
Journal:  Can J Anaesth       Date:  1995-10       Impact factor: 5.063

7.  Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran).

Authors:  D G Tincello; M J Johnstone
Journal:  Postgrad Med J       Date:  1996-11       Impact factor: 2.401

Review 8.  Ondansetron. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting.

Authors:  Anthony Markham; Eugene M Sorkin
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

9.  Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials.

Authors:  R L Aspinall; N W Goodman
Journal:  BMJ       Date:  1995-09-30

Review 10.  Volunteer models for predicting antiemetic activity of 5-HT3-receptor antagonists.

Authors:  N A Minton
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.